BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao Y, Zhao M. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrology 2009;14:33-41. [DOI: 10.1111/j.1440-1797.2009.01100.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 62] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Weiner M, Segelmark M. The clinical presentation and therapy of diseases related to anti-neutrophil cytoplasmic antibodies (ANCA). Autoimmunity Reviews 2016;15:978-82. [DOI: 10.1016/j.autrev.2016.07.016] [Cited by in Crossref: 51] [Cited by in F6Publishing: 38] [Article Influence: 10.2] [Reference Citation Analysis]
2 Holle JU, Wieczorek S, Gross WL. The Future of ANCA-associated Vasculitis. Rheumatic Disease Clinics of North America 2010;36:609-21. [DOI: 10.1016/j.rdc.2010.05.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
3 Chen Y, Bao H, Liu Z, Zhang H, Zeng C, Liu Z, Hu W. Clinico-pathological features and outcomes of patients with propylthiouracil-associated ANCA vasculitis with renal involvement. J Nephrol 2014;27:159-64. [PMID: 24570072 DOI: 10.1007/s40620-014-0063-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
4 Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol. 2013;8:139-160. [PMID: 23347350 DOI: 10.1146/annurev-pathol-011811-132453] [Cited by in Crossref: 160] [Cited by in F6Publishing: 132] [Article Influence: 20.0] [Reference Citation Analysis]
5 Parekh K, Ching D, Rahman MU, Stamp LK. Onset of Wegener's granulomatosis during therapy with golimumab for rheumatoid arthritis: a rare adverse event? Rheumatology 2010;49:1785-7. [DOI: 10.1093/rheumatology/keq101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
6 Vanoni F, Bettinelli A, Keller F, Bianchetti MG, Simonetti GD. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol 2010;25:205-12. [PMID: 19641940 DOI: 10.1007/s00467-009-1253-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
7 Qaisar H, Hossain MA, Akula M, Cheng J, Patel M, Min Z, Kuzyshyn H, Levitt M, Coley SM, Asif A. Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of. J Clin Med Res 2018;10:786-90. [PMID: 30214651 DOI: 10.14740/jocmr3530w] [Reference Citation Analysis]
8 Khosla A, Andring B, Atchie B, Zerr J, White B, Macfarlane J, Kalva SP. Systemic Vasculopathies. Radiologic Clinics of North America 2016;54:613-28. [DOI: 10.1016/j.rcl.2015.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
9 Yang J, Yao L, Dong M, Xu Q, Zhang J, Weng W, Chen F. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China. Thyroid 2017;27:1469-74. [DOI: 10.1089/thy.2017.0468] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
10 Sugiyama A, Kobayashi M, Daizo A, Suzuki M, Kawashima H, Kagami SI, Tanaka H, Suzuki Y, Matsunaga T, Kuwabara S. Diffuse Cerebral Vasoconstriction in a Intravascular Lymphoma Patient with a High Serum MPO-ANCA Level. Intern Med 2017;56:1715-8. [PMID: 28674364 DOI: 10.2169/internalmedicine.56.8051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
11 Strazzula L, Brown KK, Brieva JC, Camp BJ, Frankel HC, Kissin E, Mahlberg MJ, Mina MA, Pomeranz MK, Brownell I, Kroshinsky D. Levamisole toxicity mimicking autoimmune disease. J Am Acad Dermatol 2013;69:954-9. [PMID: 24075227 DOI: 10.1016/j.jaad.2013.07.037] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
12 Prete M, Indiveri F, Perosa F. Vasculitides: Proposal for an integrated nomenclature. Autoimmunity Reviews 2016;15:167-73. [DOI: 10.1016/j.autrev.2015.10.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sagmeister MS, Weiss M, Eichhorn P, Habicht A, Habersetzer R, Fischereder M, Schönermarck U. Case report: de novo ANCA-associated vasculitis after kidney transplantation treated with rituximab and plasma exchange. BMC Nephrol 2018;19:270. [PMID: 30340563 DOI: 10.1186/s12882-018-1086-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
14 Frazier KS, Engelhardt JA, Fant P, Guionaud S, Henry SP, Leach MW, Louden C, Scicchitano MS, Weaver JL, Zabka TS. Scientific and Regulatory Policy Committee Points-to-consider Paper*: Drug-induced Vascular Injury Associated with Nonsmall Molecule Therapeutics in Preclinical Development: Part I. Biotherapeutics. Toxicol Pathol 2015;43:915-34. [DOI: 10.1177/0192623315570340] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
15 Shochet L, Holdsworth S, Kitching AR. Animal Models of ANCA Associated Vasculitis. Front Immunol 2020;11:525. [PMID: 32373109 DOI: 10.3389/fimmu.2020.00525] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
16 Mikaelian I, Cameron M, Dalmas DA, Enerson BE, Gonzalez RJ, Guionaud S, Hoffmann PK, King NMP, Lawton MP, Scicchitano MS, Smith HW, Thomas RA, Weaver JL, Zabka TS; The Vascular Injury Working Group of the Predictive Safety Consortium. Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future. Toxicol Pathol 2014;42:635-57. [DOI: 10.1177/0192623314525686] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
17 Goh Y, Tan BY, Chong NY, Ma M, Lahiri M, Makmur A, Chan YC, Wong SBJ, Vijayan J. D-penicillamine in Wilson's disease; recognizing the transition from benefit to harm. eNeurologicalSci 2021;23:100328. [PMID: 33786384 DOI: 10.1016/j.ensci.2021.100328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li Q, Yu LC, Li FX, Wang J, Chen Y, Sun SZ. The Clinical and Pathological Features of Children With Microscopic Polyangiitis. Front Pediatr 2021;9:645785. [PMID: 33937151 DOI: 10.3389/fped.2021.645785] [Reference Citation Analysis]
19 Tran H, Tan D, Marnejon TP. Cutaneous vasculopathy associated with levamisole-adulterated cocaine. Clin Med Res 2013;11:26-30. [PMID: 22723468 DOI: 10.3121/cmr.2012.1085] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
20 Jiang JX, Keat K, Swaminathan S. ANCA-Associated Vasculitis in Inflammatory Bowel Disease. Dig Dis Sci 2019;64:3350-4. [PMID: 31093814 DOI: 10.1007/s10620-019-05654-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Ferreira C, Costa T, Marques AV. Diffuse alveolar haemorrhage secondary to propylthiouracil-induced vasculitis. BMJ Case Rep 2015;2015:bcr2014208289. [PMID: 25661751 DOI: 10.1136/bcr-2014-208289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Ayturk S, Demir MV, Yaylacı S, Tamer A. Propylthiouracil induced leukocytoclastic vasculitis: A rare manifestation. Indian J Endocrinol Metab 2013;17:339-40. [PMID: 23776917 DOI: 10.4103/2230-8210.109665] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Crowe DR, Kim PS, Mutasim DF. Clinical, histopathologic, and immunofluorescence findings in levamisole/cocaine-induced thrombotic vasculitis: Levamisole/cocaine-induced thrombotic vasculitis. Int J Dermatol 2014;53:635-7. [DOI: 10.1111/j.1365-4632.2012.05667.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Grygiel-Górniak B, Limphaibool N, Perkowska K, Puszczewicz M. Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features. Postgrad Med 2018;130:581-96. [PMID: 30071173 DOI: 10.1080/00325481.2018.1503920] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
25 Coster A, Dargent J, de Visscher N, Levecque P, Roquet-gravy P. Pyoderma gangrenosum avec anticorps anti-cytoplasme des neutrophiles de type anti-protéinase 3 (PR3-ANCA) induits par le propylthiouracile. Annales de Dermatologie et de Vénéréologie 2017;144:368-73. [DOI: 10.1016/j.annder.2017.01.018] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Csernok E, Lamprecht P, Gross WL. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 2010;22:43-8. [PMID: 19770659 DOI: 10.1097/BOR.0b013e3283323538] [Cited by in Crossref: 56] [Cited by in F6Publishing: 13] [Article Influence: 5.1] [Reference Citation Analysis]
27 Cao X, Lin W. Clinical study of renal impairment in patients with propylthiouracil-induced small-vessel vasculitis and patients with primary ANCA-associated small-vessel vasculitis. Exp Ther Med 2013;5:1619-22. [PMID: 23837042 DOI: 10.3892/etm.2013.1065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
28 Carlson AQ, Tuot DS, Jen KY, Butcher B, Graf J, Sam R, Imboden JB. Pauci-immune glomerulonephritis in individuals with disease associated with levamisole-adulterated cocaine: a series of 4 cases. Medicine (Baltimore) 2014;93:290-7. [PMID: 25398064 DOI: 10.1097/MD.0000000000000090] [Cited by in Crossref: 30] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
29 McGrath MM, Isakova T, Rennke HG, Mottola AM, Laliberte KA, Niles JL. Contaminated cocaine and antineutrophil cytoplasmic antibody-associated disease. Clin J Am Soc Nephrol 2011;6:2799-805. [PMID: 21980179 DOI: 10.2215/CJN.03440411] [Cited by in Crossref: 104] [Cited by in F6Publishing: 37] [Article Influence: 10.4] [Reference Citation Analysis]
30 Suneja M, Baiswar S, Vogelgesang SA. Hydralazine Associated Pauci-Immune Glomerulonephritis: . JCR Journal of Clinical Rheumatology 2014;20:99-102. [DOI: 10.1097/rhu.0000000000000049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
31 Zhou D, Zhang P, Zhang Y, Zhang Y, Zhang X, Li J, Zhou Z, Zhu N. Main tract stenosis complicated by granulomatous with polyangiitis: A case report. Exp Ther Med 2020;19:3332-6. [PMID: 32266030 DOI: 10.3892/etm.2020.8603] [Reference Citation Analysis]
32 Kawahara H, Nakashima A, Zoshima T, Kawano M. Contribution of HLA-DRB1 * 09: 01 allele to development of minocycline induced antineutrophil cytoplasmic antibody (ANCA)-associated cutaneous vasculitis: report of two cases. Mod Rheumatol Case Rep 2020;4:267-71. [PMID: 33086995 DOI: 10.1080/24725625.2020.1738983] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Bilge NS, Kaşifoğlu T, Korkmaz C. PTU-induced ANCA-positive vasculitis: an innocent or a life-threatening adverse effect? Rheumatol Int 2013;33:117-20. [PMID: 22228488 DOI: 10.1007/s00296-011-2280-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
34 Carubbi F, Alunno A, Cipriani P, Bistoni O, Scipioni R, Liakouli V, Ruscitti P, Berardicurti O, Di Bartolomeo S, Gerli R, Giacomelli R. Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls. Curr Rheumatol Rev 2019;15:27-43. [PMID: 29557752 DOI: 10.2174/1573397114666180320113603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Babar F, Posner JN, Obah EA. Hydralazine-induced pauci-immune glomerulonephritis: intriguing case series with misleading diagnoses. J Community Hosp Intern Med Perspect 2016;6:30632. [PMID: 27124161 DOI: 10.3402/jchimp.v6.30632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
36 Kambham N. Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases. Adv Anat Pathol. 2012;19:111-124. [PMID: 22313839 DOI: 10.1097/pap.0b013e318248b7a1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
37 Koyama Y, Adachi K, Yagi M, Go Y, Orimoto K, Kawai S, Uenaka N, Okazaki M, Asaoka M, Teraoka S, Ueda A, Miyahara K, Kawate T, Kaise H, Yamada K, Ishikawa T. Successful treatment of G-CSF-related aortitis with prednisolone during preoperative chemotherapy for breast cancer: a case report. Surg Case Rep 2021;7:23. [PMID: 33443626 DOI: 10.1186/s40792-021-01111-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
38 Cardona Attard CD, Gruppetta M, Vassallo J, Vella S. Carbimazole-induced exudative pleural effusions. BMJ Case Rep 2016;2016:bcr2016215080. [PMID: 27045053 DOI: 10.1136/bcr-2016-215080] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
39 Nolan AL, Jen KY. Pathologic manifestations of levamisole-adulterated cocaine exposure. Diagn Pathol 2015;10:48. [PMID: 25943359 DOI: 10.1186/s13000-015-0279-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
40 Houben E, Bax WA, van Dam B, Slieker WAT, Verhave G, Frerichs FCP, van Eijk IC, Boersma WG, de Kuyper GTM, Penne EL. Diagnosing ANCA-associated vasculitis in ANCA positive patients: A retrospective analysis on the role of clinical symptoms and the ANCA titre. Medicine (Baltimore) 2016;95:e5096. [PMID: 27749588 DOI: 10.1097/MD.0000000000005096] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
41 Chen M, Gao Y, Guo XH, Zhao MH. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis. Nat Rev Nephrol 2012;8:476-83. [PMID: 22664738 DOI: 10.1038/nrneph.2012.108] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
42 Ramponi G, Folci M, De Santis M, Damoiseaux JGMC, Selmi C, Brunetta E. The biology, pathogenetic role, clinical implications, and open issues of serum anti-neutrophil cytoplasmic antibodies. Autoimmun Rev 2021;20:102759. [PMID: 33476813 DOI: 10.1016/j.autrev.2021.102759] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
43 Galante JR, Daruwalla CP, Roberts ISD, Haynes R, Storey BC, Bottomley MJ. An unusual presentation of propylthiouracil-induced anti-MPO and PR3 positive ANCA vasculitis with associated anti-GBM antibodies, IgA nephropathy and an IgG4 interstitial infiltrate: a case report. BMC Nephrol 2020;21:295. [PMID: 32703233 DOI: 10.1186/s12882-020-01964-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
44 Fujimoto S, Ueda N, Nishimura N, Naito A, Hiura J, Mashiba K, Ikai A, Marutsuka K, Mizuno K. Clozapine-induced antineutrophil cytoplasmic antibody-associated vasculitis: a case report. Mod Rheumatol Case Rep 2020;4:70-3. [PMID: 33086971 DOI: 10.1080/24725625.2019.1628413] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Lopes Caçola R, Morais SA, Carvalho R, Môço R. Bilateral dacryoadenitis as initial presentation of a locally aggressive and unresponsive limited form of orbital granulomatosis with polyangiitis. BMJ Case Rep 2016;2016:bcr2015214099. [PMID: 27170605 DOI: 10.1136/bcr-2015-214099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
46 Ozen S. The "other" vasculitis syndromes and kidney involvement. Pediatr Nephrol 2010;25:1633-9. [PMID: 19898878 DOI: 10.1007/s00467-009-1327-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
47 Wedi B. Definitions and mechanisms of drug hypersensitivity. Expert Rev Clin Pharmacol 2010;3:539-51. [PMID: 22111682 DOI: 10.1586/ecp.10.32] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
48 Moiseev S, Cohen Tervaert JW, Arimura Y, Bogdanos DP, Csernok E, Damoiseaux J, Ferrante M, Flores-Suárez LF, Fritzler MJ, Invernizzi P, Jayne D, Jennette JC, Little MA, McAdoo SP, Novikov P, Pusey CD, Radice A, Salama AD, Savige JA, Segelmark M, Shoenfeld Y, Sinico RA, Sousa MJ, Specks U, Terrier B, Tzioufas AG, Vermeire S, Zhao MH, Bossuyt X. 2020 international consensus on ANCA testing beyond systemic vasculitis. Autoimmun Rev 2020;19:102618. [PMID: 32663621 DOI: 10.1016/j.autrev.2020.102618] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 19.0] [Reference Citation Analysis]
49 Zhang J, Hanig JP, De Felice AF. Biomarkers of endothelial cell activation: candidate markers for drug-induced vasculitis in patients or drug-induced vascular injury in animals. Vascul Pharmacol 2012;56:14-25. [PMID: 21968053 DOI: 10.1016/j.vph.2011.09.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
50 Giraud-Kerleroux L, Bernigaud C, Droumaguet C, Thai LH, Marciano-Fellous L, Thomas L, Charpentier C, Helbert-Davidson S, Fardet L, Hüe S, Ingen-Housz-Oro S. [Purpura in a young woman with hyperthyroidism]. Rev Med Interne 2021;42:509-12. [PMID: 33846035 DOI: 10.1016/j.revmed.2021.03.330] [Reference Citation Analysis]
51 Tomkins M, Tudor RM, Smith D, Agha A. Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis and agranulocytosis in a patient with Graves' disease. Endocrinol Diabetes Metab Case Rep 2020;2020:EDM190135. [PMID: 31917676 DOI: 10.1530/EDM-19-0135] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Kallenberg CG, Zhao MH. Evolving concepts in pathogenesis and treatment of ANCA-associated systemic vasculitides. Nephrology (Carlton) 2009;14:1-2. [PMID: 19335840 DOI: 10.1111/j.1440-1797.2009.01093.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
53 Lutalo PM, D'Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener's granulomatosis). J Autoimmun. 2014;48-49:94-98. [PMID: 24485158 DOI: 10.1016/j.jaut.2014.01.028] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 14.1] [Reference Citation Analysis]
54 Li C, Zhou ML, Liang DD, Wang JJ, Yang J, Zeng CH, Liu ZH, Zhang HT. Treatment and clinicopathological characteristics of lupus nephritis with anti-neutrophil cytoplasmic antibody positivity: a case-control study. BMJ Open 2017;7:e015668. [PMID: 28756384 DOI: 10.1136/bmjopen-2016-015668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
55 Liu Y, Huang C. Woman With Painful Purpura. Annals of Emergency Medicine 2012;60:260-8. [DOI: 10.1016/j.annemergmed.2012.01.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Chen M, Cui Z, Zhao MH. ANCA-associated vasculitis and anti-GBM disease: the experience in China. Nephrol Dial Transplant. 2010;25:2062-2065. [PMID: 20228070 DOI: 10.1093/ndt/gfq134] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
57 Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-sallé D. Extensive levamisole-induced vasculitis. Clin Exp Dermatol 2017;42:413-5. [DOI: 10.1111/ced.13085] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
58 Nakamura J, Nishi TM, Yamashita S, Nakamura H, Sato K, Oda Y, Iyama A. Pegfilgrastim-associated large-vessel vasculitis developed during adjuvant chemotherapy for breast cancer: A case report and review of the literature. J Oncol Pharm Pract 2020;26:1785-90. [DOI: 10.1177/1078155220910800] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
59 Weng CH, Liu ZC. Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis. Chin Med J (Engl) 2019;132:2848-55. [PMID: 31856057 DOI: 10.1097/CM9.0000000000000539] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
60 Wan P, Zhao X, Hunasehally RYP, Shi R, Zheng J. Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide: Propylthiouracil-induced ANCA-positive erythema nodosum treated with thalidomide. International Journal of Dermatology 2012;51:345-8. [DOI: 10.1111/j.1365-4632.2011.05135.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
61 Vrancken AF, Said G. Vasculitic neuropathy. Peripheral Nerve Disorders. Elsevier; 2013. pp. 463-83. [DOI: 10.1016/b978-0-444-52902-2.00026-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
62 Young JWS, Shear NH. Cutaneous Drug Reactions in the Elderly. Drugs Aging 2017;34:655-72. [PMID: 28801750 DOI: 10.1007/s40266-017-0483-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
63 de Groot K, Märker-Hermann E. [Secondary vasculitides and vasculitis mimics]. Z Rheumatol 2012;71:771-4. [PMID: 22956168 DOI: 10.1007/s00393-012-0986-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]